oxaprozin

Generic: oxaprozin

Labeler: amneal pharmaceuticals ny llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name oxaprozin
Generic Name oxaprozin
Labeler amneal pharmaceuticals ny llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

oxaprozin 600 mg/1

Manufacturer
Amneal Pharmaceuticals NY LLC

Identifiers & Regulatory

Product NDC 69238-1120
Product ID 69238-1120_b77a2557-2013-46ce-8d87-a25f17be5b89
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208633
Listing Expiration 2026-12-31
Marketing Start 2017-05-04

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 692381120
Hyphenated Format 69238-1120

Supplemental Identifiers

RxCUI
312132
UNII
MHJ80W9LRB
NUI
N0000000160 M0001335 N0000175722

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oxaprozin (source: ndc)
Generic Name oxaprozin (source: ndc)
Application Number ANDA208633 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 600 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (69238-1120-1)
  • 500 TABLET in 1 BOTTLE (69238-1120-5)
source: ndc

Packages (2)

69238-1120-1 100 TABLET in 1 BOTTLE (69238-1120-1) 69238-1120-5 500 TABLET in 1 BOTTLE (69238-1120-5)

Ingredients (1)

oxaprozin (600 mg/1)

Linked Drug Pages (1)

Oxaprozin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b77a2557-2013-46ce-8d87-a25f17be5b89", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "unii": ["MHJ80W9LRB"], "rxcui": ["312132"], "spl_set_id": ["d9b0ca6c-4c53-4f6e-918b-02a8c472a194"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (69238-1120-1)", "package_ndc": "69238-1120-1", "marketing_start_date": "20170504"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (69238-1120-5)", "package_ndc": "69238-1120-5", "marketing_start_date": "20170504"}], "brand_name": "Oxaprozin", "product_id": "69238-1120_b77a2557-2013-46ce-8d87-a25f17be5b89", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "69238-1120", "generic_name": "Oxaprozin", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxaprozin", "active_ingredients": [{"name": "OXAPROZIN", "strength": "600 mg/1"}], "application_number": "ANDA208633", "marketing_category": "ANDA", "marketing_start_date": "20170504", "listing_expiration_date": "20261231"}